Josephine van Dongen

8 Summary and general discussion 201 20. Thomas S,Donato CM, Roczo-Farkas S,Hua J, Bines JE.Australian Rotavirus Surveillance Program: Annual Repor t, 2019. Commun Dis Intell. 2021;(45). https://pubmed.ncbi.nlm.nih. gov/33573535/ 21. Staat MA, Payne DC, Parashar UD. Continued evidence of the impact of Rotavirus Vaccine in Children Less than 3 Years of age from the US NewVaccine Surveillance Network- a multi-site active surveillance program, 2006-2016. Clin Infect Dis . Published online 2020:16. doi:10.1017/CBO9781107415324.004 22. Ituriza-Gomara M, Hungerdorf D. EuroRotaNet: Annual repor t 2018. EuroRotanet. Published online 2019. https://www.thl.fi/documents/533963/1527557/ EuroRotaNetAnnualRepor t6th_2014.pdf/7e4386c0-0e09-4e18-8576-95031eaf2680 23. McDonald SM, McKell AO, Rippinger CM, et al. Diversity and Relationships of Cocirculating Modern Human Rotaviruses Revealed Using Large-Scale Comparative Genomics. J Virol. 2012;86(17):9148-9162. doi:10.1128/jvi.01105-12 24. Payne DC, Parashar UD. Chapter 13 Rotavirus. In: Vaccine Preventable Disease Surveillance Manual. ; 2014:1-16. 25. Bowen MD, Mijatovic-Rustempasic S, Esona MD, et al. Rotavirus strain trends during the postlicensure vaccine era: United States, 2008-2013. J Infect Dis. Published online 2016. doi:10.1093/infdis/jiw233 26. Markkula J, Hemming-harlo M, Savolainen-kopra C, Vesikari T. Continuing rotavirus circulation in children and adults despite high coverage rotavirus vaccination in Finland. J Infect. Published online 2019. doi:10.1016/j.jinf.2019.09.009 27. Maguire JE, Epi M, Appepi M, Glasgow K, Hons B, Glass K. Rotavirus Epidemiology and Monovalent Rotavirus Vaccine Effectiveness in Australia : 2010 – 2017. 2019;144(4):2010-2017. doi:10.1542/peds.2019-1024 28. Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States – vaccine uptake, effectiveness, and impact. Expert Rev Vaccines . Published online 2018. doi:10.1080/14760584.2018.1489724 29. Donato CM, Roczo-Farkas S, Kirkwood CD, Barnes GL, Bines JE. Rotavirus disease and genotype diversity in older children and adults in Australia. J Infect Dis . Published online 2020:1- 11. doi:10.1093/infdis/jiaa430 30. Hahné S, Hooiveld M, Vennema H, et al. Exceptionally low rotavirus incidence in the Netherlands in 2013/14 in the absence of rotavirus vaccination. Euro Surveill. 2014;19. 31. van Gaalen RD, van de Kassteele J, Hahne SJM, Bruijning-Verhagen P, Wallinga J. Determinants of Rotavirus Transmission: A Lag Nonlinear Time Series Analysis. Epidemiology. 2017;28(4):503-513. doi:10.1097/ede.0000000000000654 32. Verberk JDM, Pijnacker R, Bruijning-Verhagen P, et al. Biennial Pattern of Rotavirus Gastroenteritis in The Netherlands and a Shifting Age Distribution Following a Low Rotavirus Season, 2010-2016. Pediatr Infect Dis J . 2018;37:248-250. doi:10.1097/INF.0000000000001880 33. Roczo-Farkas S, Kirkwood CD, Cowley D, et al. The impact of rotavirus vaccines on genotype diversity: A comprehensive analysis of 2 decades of australian surveillance data. J Infect Dis. 2018;218(4):546-554. doi:10.1093/infdis/jiy197 34. Thanh HD, Tran VT, Lim I, Kim W. Emergence of Human G2P[4] Rotaviruses in the Post-vaccination Era in South Korea: Footprints of Multiple Interspecies Re- assor tment Events. doi:10.1038/s41598-018-24511-y 35. Mukhopadhya I, Murdoch H, Berry S, et al. Changing molecular epidemiology of rotavirus infection after introduction of monovalent rotavirus vaccination in Scotland. Vaccine . Published online 2017. doi:10.1016/j.vaccine.2016.11.028 36. Braeckman T, Herck K Van, Meyer N, et al. Effectiveness of rotavirus vaccination in